Selected research
Market Structure
Global Promethazine Hydrochloride Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Promethazine Hydrochloride Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Promethazine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Promethazine Hydrochloride Injection include Southwest Pharmaceutical, Tianjin Jinyao Group, Shanghai Shyndec Pharmaceutical, Shanghai Harvest Pharmaceutical, Sanofi, Jinling Pharmaceutical, Jilin Centennium Hanke Pharmacy, Pfizer and Hunan Hansen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Promethazine Hydrochloride Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Promethazine Hydrochloride Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Promethazine Hydrochloride Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Promethazine Hydrochloride Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
Promethazine Hydrochloride Injection Segment by Company
Southwest Pharmaceutical
Tianjin Jinyao Group
Shanghai Shyndec Pharmaceutical
Shanghai Harvest Pharmaceutical
Sanofi
Jinling Pharmaceutical
Jilin Centennium Hanke Pharmacy
Pfizer
Hunan Hansen
Guangdong Southland Pharmaceutical
Hikma Pharmaceuticals
Advacare Pharma
Promethazine Hydrochloride Injection Segment by Type
Intravenous Drip
Intramuscular Injection
Promethazine Hydrochloride Injection Segment by Application
Hospital
Clinics
Other
Promethazine Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Promethazine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Promethazine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Promethazine Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Promethazine Hydrochloride Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Promethazine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Promethazine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Promethazine Hydrochloride Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Intravenous Drip
- Intramuscular Injection
Applications
- Hospital
- Clinics
- Other
Companies covered
- Southwest Pharmaceutical
- Tianjin Jinyao Group
- Shanghai Shyndec Pharmaceutical
- Shanghai Harvest Pharmaceutical
- Sanofi
- Jinling Pharmaceutical
- Jilin Centennium Hanke Pharmacy
- Pfizer
- Hunan Hansen
- Guangdong Southland Pharmaceutical
- Hikma Pharmaceuticals
- Advacare Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Promethazine Hydrochloride Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Promethazine Hydrochloride Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Promethazine Hydrochloride Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Promethazine Hydrochloride Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Promethazine Hydrochloride Injection Market Dynamics
- 2.1 Promethazine Hydrochloride Injection Industry Trends
- 2.2 Promethazine Hydrochloride Injection Industry Drivers
- 2.3 Promethazine Hydrochloride Injection Industry Opportunities and Challenges
- 2.4 Promethazine Hydrochloride Injection Industry Restraints
3 Promethazine Hydrochloride Injection Market by Manufacturers
- 3.1 Global Promethazine Hydrochloride Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global Promethazine Hydrochloride Injection Sales by Manufacturers (2021-2026)
- 3.3 Global Promethazine Hydrochloride Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Promethazine Hydrochloride Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Promethazine Hydrochloride Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Promethazine Hydrochloride Injection Manufacturers, Product Type & Application
- 3.7 Global Promethazine Hydrochloride Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Promethazine Hydrochloride Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Promethazine Hydrochloride Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Promethazine Hydrochloride Injection Tier 1, Tier 2, and Tier 3
4 Promethazine Hydrochloride Injection Market by Type
- 4.1 Promethazine Hydrochloride Injection Type Introduction
- 4.1.1 Intravenous Drip
- 4.1.2 Intramuscular Injection
- 4.2 Global Promethazine Hydrochloride Injection Sales by Type
- 4.2.1 Global Promethazine Hydrochloride Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Promethazine Hydrochloride Injection Sales by Type (2021-2032)
- 4.2.3 Global Promethazine Hydrochloride Injection Sales Market Share by Type (2021-2032)
- 4.3 Global Promethazine Hydrochloride Injection Revenue by Type
- 4.3.1 Global Promethazine Hydrochloride Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Promethazine Hydrochloride Injection Revenue by Type (2021-2032)
- 4.3.3 Global Promethazine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
5 Promethazine Hydrochloride Injection Market by Application
- 5.1 Promethazine Hydrochloride Injection Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Promethazine Hydrochloride Injection Sales by Application
- 5.2.1 Global Promethazine Hydrochloride Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Promethazine Hydrochloride Injection Sales by Application (2021-2032)
- 5.2.3 Global Promethazine Hydrochloride Injection Sales Market Share by Application (2021-2032)
- 5.3 Global Promethazine Hydrochloride Injection Revenue by Application
- 5.3.1 Global Promethazine Hydrochloride Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Promethazine Hydrochloride Injection Revenue by Application (2021-2032)
- 5.3.3 Global Promethazine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
6 Global Promethazine Hydrochloride Injection Sales by Region
- 6.1 Global Promethazine Hydrochloride Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Promethazine Hydrochloride Injection Sales by Region (2021-2032)
- 6.2.1 Global Promethazine Hydrochloride Injection Sales by Region (2021-2026)
- 6.2.2 Global Promethazine Hydrochloride Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Promethazine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Promethazine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Promethazine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Promethazine Hydrochloride Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Promethazine Hydrochloride Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Promethazine Hydrochloride Injection Revenue by Region
- 7.1 Global Promethazine Hydrochloride Injection Revenue by Region
- 7.1.1 Global Promethazine Hydrochloride Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Promethazine Hydrochloride Injection Revenue by Region (2021-2026)
- 7.1.3 Global Promethazine Hydrochloride Injection Revenue by Region (2027-2032)
- 7.1.4 Global Promethazine Hydrochloride Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Promethazine Hydrochloride Injection Revenue (2021-2032)
- 7.2.2 North America Promethazine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Promethazine Hydrochloride Injection Revenue (2021-2032)
- 7.3.2 Europe Promethazine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Promethazine Hydrochloride Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific Promethazine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Promethazine Hydrochloride Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Promethazine Hydrochloride Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Southwest Pharmaceutical
- 8.1.1 Southwest Pharmaceutical Company Information
- 8.1.2 Southwest Pharmaceutical Business Overview
- 8.1.3 Southwest Pharmaceutical Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Southwest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 8.1.5 Southwest Pharmaceutical Recent Developments
- 8.2 Tianjin Jinyao Group
- 8.2.1 Tianjin Jinyao Group Company Information
- 8.2.2 Tianjin Jinyao Group Business Overview
- 8.2.3 Tianjin Jinyao Group Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tianjin Jinyao Group Promethazine Hydrochloride Injection Product Portfolio
- 8.2.5 Tianjin Jinyao Group Recent Developments
- 8.3 Shanghai Shyndec Pharmaceutical
- 8.3.1 Shanghai Shyndec Pharmaceutical Company Information
- 8.3.2 Shanghai Shyndec Pharmaceutical Business Overview
- 8.3.3 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shanghai Shyndec Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 8.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 8.4 Shanghai Harvest Pharmaceutical
- 8.4.1 Shanghai Harvest Pharmaceutical Company Information
- 8.4.2 Shanghai Harvest Pharmaceutical Business Overview
- 8.4.3 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai Harvest Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 8.4.5 Shanghai Harvest Pharmaceutical Recent Developments
- 8.5 Sanofi
- 8.5.1 Sanofi Company Information
- 8.5.2 Sanofi Business Overview
- 8.5.3 Sanofi Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sanofi Promethazine Hydrochloride Injection Product Portfolio
- 8.5.5 Sanofi Recent Developments
- 8.6 Jinling Pharmaceutical
- 8.6.1 Jinling Pharmaceutical Company Information
- 8.6.2 Jinling Pharmaceutical Business Overview
- 8.6.3 Jinling Pharmaceutical Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jinling Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 8.6.5 Jinling Pharmaceutical Recent Developments
- 8.7 Jilin Centennium Hanke Pharmacy
- 8.7.1 Jilin Centennium Hanke Pharmacy Company Information
- 8.7.2 Jilin Centennium Hanke Pharmacy Business Overview
- 8.7.3 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Jilin Centennium Hanke Pharmacy Promethazine Hydrochloride Injection Product Portfolio
- 8.7.5 Jilin Centennium Hanke Pharmacy Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Promethazine Hydrochloride Injection Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 Hunan Hansen
- 8.9.1 Hunan Hansen Company Information
- 8.9.2 Hunan Hansen Business Overview
- 8.9.3 Hunan Hansen Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Hunan Hansen Promethazine Hydrochloride Injection Product Portfolio
- 8.9.5 Hunan Hansen Recent Developments
- 8.10 Guangdong Southland Pharmaceutical
- 8.10.1 Guangdong Southland Pharmaceutical Company Information
- 8.10.2 Guangdong Southland Pharmaceutical Business Overview
- 8.10.3 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Guangdong Southland Pharmaceutical Promethazine Hydrochloride Injection Product Portfolio
- 8.10.5 Guangdong Southland Pharmaceutical Recent Developments
- 8.11 Hikma Pharmaceuticals
- 8.11.1 Hikma Pharmaceuticals Company Information
- 8.11.2 Hikma Pharmaceuticals Business Overview
- 8.11.3 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hikma Pharmaceuticals Promethazine Hydrochloride Injection Product Portfolio
- 8.11.5 Hikma Pharmaceuticals Recent Developments
- 8.12 Advacare Pharma
- 8.12.1 Advacare Pharma Company Information
- 8.12.2 Advacare Pharma Business Overview
- 8.12.3 Advacare Pharma Promethazine Hydrochloride Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Advacare Pharma Promethazine Hydrochloride Injection Product Portfolio
- 8.12.5 Advacare Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Promethazine Hydrochloride Injection Value Chain Analysis
- 9.1.1 Promethazine Hydrochloride Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Promethazine Hydrochloride Injection Production Mode & Process
- 9.2 Promethazine Hydrochloride Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Promethazine Hydrochloride Injection Distributors
- 9.2.3 Promethazine Hydrochloride Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst